Active Immunization Against LHRH: I. Effects of Conjugation Site and Dose

Publisher Website
Google Scholar
Abstract
Active immunization against LHRH is a promising method of contraception for men. In order to be acceptable, sufficient amounts of anti-LHRH antibodies must be induced rapidly after vaccination. In previously reported animal studies, we found that it took considerable time (up to 5 months) to obtain antibody titers (AT) that were sufficiently high for complete suppression of spermatogenesis. The possibility of accelerating the immune response to LHRH by increasing the dose of immunogen was investigated in the male rat. Six doses of LHRH conjugated to tetanus toxoid (TT) in the 10 position (LHRH10-TT), ranging from 2.5 to 612 .mu.g, and three doses of LHRH1-TT (50 to 612 .mu.g) were tested. The magnitude of the immune response did not depend on the dose of the antigen, provided a threshold dose had been surpassed. Antigenicity of LHRH conjugated to TT at either the 1-, 6-, or 10-position was compared in rats and rabbits. In both species LHRH1-TT induced sufficient antibody concentrations to suppress pituitary gonadotropins (LH and FSH) and, subsequently, serum testosterone(T) levels faster than either the 6- or 10-conjugates. Only materials permitted for use in humans were utilized in these experiments. Conclusion: Active immunization against LHRH conjugated to TT at the 1-position has potential as a fast, convenient method of male contraception.

This publication has 25 references indexed in Scilit: